Delivery Order SPE2DB20D2014-SPE2DB25FD06W
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 100 mg tablets (60-count units) valued at $2,048.51. This firm fixed-price delivery order, which is expected to be completed by August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of VIMPAT 150 mg tablets (60-count units) with a ceiling value of $2,892.26. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by September 23, 2025, and will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of VIMPAT 150 mg tablets (60 count) valued at $1,013.36. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for VIMPAT 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,524.74. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 21, 2025. The contract is unset-aside and represents a child order under the company's larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIMPAT 150 MG tablets. The delivery order, valued at $1,240.24, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.40 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in a 200 ml volume. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, completed on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 100 MG TABLET 60S for a total ceiling value of $1,484.97. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency awarded a $1,455.99 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for VIMPAT 10 mg/mL Solution in 200 mL quantities. This firm fixed price order, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was awarded without a set-aside designation through competitive procurement, and performance will occur at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VIMPAT 200 MG tablets in a quantity of 60 units, with a contract ceiling value of $1,089.82. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract has an ultimate completion date of July 28, 2025, and AmerisourceBergen will perform this work from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,279.00 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of VIMPAT 10 mg/mL solution in 200mL quantities. This is a firm fixed price, non-set-aside contract with a completion date of June 6, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD06WDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,707.00 to AmerisourceBergen Drug Corp for the supply of VIMPAT 100 mg tablets (60-count units). This contract, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. VIMPAT, an anti-epileptic medication, falls within the neurological treatment category that AmerisourceBergen supplies through its federal contract portfolio, supporting Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/22/25 |